Deep Brain Stimulation in Parkinson's Disease Patients Over 75 Years of Age: A Single‐Institution Retrospective Analysis
CNS Neuroscience & Therapeutics · 2025-05 · 31 (5)
DOI: 10.1111/cns.70397 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 14.05.2025. Verfasst von Xin Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xi'an Science and Technology Plan Project, Rapid Response Research Project of Air Force Medical University, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
Aim
Elderly patients (aged 75 years and older) with Parkinson's disease (PD) are commonly considered unsuitable for deep brain stimulation (DBS) because of its limited benefits for this population and high risk. Understanding therapeutic heterogeneity in terms of effectiveness and safety can help in personalized prognostic and preoperative evaluations.
Methods
The clinical data of 1680 PD patients who underwent DBS surgery in our hospital between April 2007 and July 2023 were retrospectively analyzed. Sixty‐eight of the patients were aged 75 years or older at the time of treatment. The patients were stratified into two groups according to the disease duration: 38 had PD for < 10 years, and 30 had PD for ≥ 10 years. The baseline data, including sex, Hoehn–Yahr scores, PD classification, comorbidities, levodopa responsiveness, anesthesia and operation methods, were compared to confirm the comparability of the results. The Movement Disorder Society‐sponsored revision of the unified Parkinson's disease rating scale‐part 3 (MDS‐UPDRS‐III) score (off‐ or on‐medication condition, off‐medication/on‐stimulation condition, and on‐medication/on‐stimulation condition), levodopa equivalent daily dose (LEDD), 39‐item Parkinson's disease questionnaire (PDQ‐39) score, activities of daily living (ADL) scale score, and adverse events were obtained and compared between the two groups preoperatively and at the postoperative follow‐up.
Results
Among the two groups of patients, no significant differences in sex, PD classification, comorbidities, levodopa responsiveness, anesthesia method, or operation method were observed. In both groups of patients, the postoperative MDS‐UPDRS‐III scores were significantly lower than the preoperative MDS‐UPDRS‐III scores. However, the LEDD, PDQ‐39 score, and ADL score did not decrease significantly in patients with a disease duration ≥ 10 years. The incidence rate of complications was significantly higher in this group of patients.
Conclusions
DBS surgery is effective for improving motor symptoms in elderly PD patients (aged 75 years and older) in the short and long term. Patients with a longer duration of disease (≥ 10 years) cannot easily reduce the use of anti‐Parkinsonian drugs, improve their quality of life, or improve their ability to perform daily living activities. These PD patients often suffer relatively more temporary complications, which should be taken seriously by doctors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
- Department of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Xi'an Medical University, Xi'an, Shaanxi, China.
Förderung
- Xi'an Science and Technology Plan Project
- Rapid Response Research Project of Air Force Medical University
- Key Research and Development Projects of Shaanxi Province
Zitieren
APA
Wang, X., Wang, J., Li, N., Wen, Y., Wang, B., Kou, H., Fu, J., Qu, H., Qiu, C., Jing, Z., Su, M., Zheng, Z., Wang, X., & Qu, Y. (2025). Deep Brain Stimulation in Parkinson's Disease Patients Over 75 Years of Age: A Single‐Institution Retrospective Analysis. CNS Neuroscience & Therapeutics, 31(5). https://doi.org/10.1111/cns.70397
Vancouver
Wang X, Wang J, Li N, Wen Y, Wang B, Kou H, et al. Deep Brain Stimulation in Parkinson's Disease Patients Over 75 Years of Age: A Single‐Institution Retrospective Analysis. CNS Neuroscience & Therapeutics. 2025;31(5). doi:10.1111/cns.70397
BibTeX
@article{Wang2025,
author = {Wang, Xin and Wang, Jing and Li, Nan and Wen, Yuqi and Wang, Bao and Kou, Huijuan and Fu, Jian and Qu, Hongwen and Qiu, Chun and Jing, Zixuan and Su, Mingming and Zheng, Zhaohui and Wang, Xuelian and Qu, Yan},
title = {Deep Brain Stimulation in Parkinson's Disease Patients Over 75 Years of Age: A Single‐Institution Retrospective Analysis},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {5},
doi = {10.1111/cns.70397}
}
EUVIMED